Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $2.59 billion. The enterprise value is $1.86 billion.
| Market Cap | 2.59B |
| Enterprise Value | 1.86B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 113.29 million shares outstanding. The number of shares has increased by 24.83% in one year.
| Current Share Class | 113.29M |
| Shares Outstanding | 113.29M |
| Shares Change (YoY) | +24.83% |
| Shares Change (QoQ) | +5.55% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 108.19% |
| Float | 112.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.44 |
| Forward PS | 19.90 |
| PB Ratio | 4.59 |
| P/TBV Ratio | 4.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 26.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.95, with a Debt / Equity ratio of 0.37.
| Current Ratio | 16.95 |
| Quick Ratio | 16.56 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.95 |
Financial Efficiency
Return on equity (ROE) is -65.74% and return on invested capital (ROIC) is -35.05%.
| Return on Equity (ROE) | -65.74% |
| Return on Assets (ROA) | -30.16% |
| Return on Invested Capital (ROIC) | -35.05% |
| Return on Capital Employed (ROCE) | -39.21% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | $282,250 |
| Profits Per Employee | -$1.33M |
| Employee Count | 252 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.47% in the last 52 weeks. The beta is 0.94, so VRDN's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +35.47% |
| 50-Day Moving Average | 18.70 |
| 200-Day Moving Average | 23.96 |
| Relative Strength Index (RSI) | 69.26 |
| Average Volume (20 Days) | 1,959,061 |
Short Selling Information
The latest short interest is 18.92 million, so 16.70% of the outstanding shares have been sold short.
| Short Interest | 18.92M |
| Short Previous Month | 17.34M |
| Short % of Shares Out | 16.70% |
| Short % of Float | 16.82% |
| Short Ratio (days to cover) | 7.54 |
Income Statement
In the last 12 months, VRDN had revenue of $71.13 million and -$334.03 million in losses. Loss per share was -$3.46.
| Revenue | 71.13M |
| Gross Profit | -253.55M |
| Operating Income | -405.20M |
| Pretax Income | -386.97M |
| Net Income | -334.03M |
| EBITDA | -404.73M |
| EBIT | -405.20M |
| Loss Per Share | -$3.46 |
Balance Sheet
The company has $981.53 million in cash and $244.73 million in debt, with a net cash position of $736.80 million or $6.50 per share.
| Cash & Cash Equivalents | 981.53M |
| Total Debt | 244.73M |
| Net Cash | 736.80M |
| Net Cash Per Share | $6.50 |
| Equity (Book Value) | 662.10M |
| Book Value Per Share | 4.98 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was -$333.34 million and capital expenditures -$1.70 million, giving a free cash flow of -$335.04 million.
| Operating Cash Flow | -333.34M |
| Capital Expenditures | -1.70M |
| Depreciation & Amortization | 468,000 |
| Net Borrowing | 224.18M |
| Free Cash Flow | -335.04M |
| FCF Per Share | -$2.96 |
Margins
| Gross Margin | n/a |
| Operating Margin | -569.68% |
| Pretax Margin | -544.06% |
| Profit Margin | n/a |
| EBITDA Margin | -569.03% |
| EBIT Margin | -569.68% |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.83% |
| Shareholder Yield | -24.83% |
| Earnings Yield | -12.89% |
| FCF Yield | -12.93% |
Analyst Forecast
The average price target for VRDN is $36.63, which is 60.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.63 |
| Price Target Difference | 60.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 102.11% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 0.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.93 |
| Piotroski F-Score | 4 |